阿尔茨海默病遗传风险中的抑制P300子过程和神经补偿:时间空间主要组件分析的案例
Elizabeth R Paitel1, Kristy A Nielson1,2
1Department of Psychology, Marquette University, Milwaukee, Wisconsin, USA.
Psychophysiology
|September 30, 2024
概括
患有阿尔茨海默氏症风险基因 (APOE ε4) 的健康老年人表现出不同的大脑活动模式. 时间空间PCA显示前部P300活动增加,表明神经补偿早期认知变化.
科学领域:
- 认知神经科学 认知神经科学
- 神经成像是一种神经成像.
- 衰老研究研究 衰老研究
背景情况:
- 阿尔茨海默病 (AD) 与P300事件相关潜力 (ERP) 变化有关,包括振幅降低和延迟延迟.
- 早期AD相关的神经变化发生在症状出现之前,使得无症状的AD风险对研究早期检测至关重要.
- 阿波利波蛋白-E (APOE) ε4等位基因是阿尔茨海默氏症的重要遗传风险因素,其载体表现出改变的P300延迟.
研究的目的:
- 在健康的老年人中,在抑制控制期间研究P300活性中的差异,具有或没有APOE ε4风险等位基因.
- 探索时间空间主要组件分析 (tsPCA) 在剖析P300窗口内重叠的子过程中的实用性.
- 确定APOE ε4载体中的P300变化是否反映了早期的神经补偿机制.
主要方法:
- 招募了健康,认知完整的老年人,根据APOE ε4载体状态 (25 ε4和20 ε4+) 分层.
- 在录制脑电图 (EEG) 时进行停止信号抑制控制任务.
- 分析了P300活动,使用传统的ERP指标 (振幅) 和tsPCA来隔离时间空间组件.
主要成果:
- 传统的P300振幅指标在APOE ε4载体和非载体之间没有区别.
- tsPCA确定了两个不同的P300因素:与注意力分配相关的后部组件和与绩效监测相关的前部组件.
- 与非载体相比,APOE ε4载体在前部P300因子中显示出明显更大的活性,尽管任务性能相似.
结论:
- 时间空间PCA提供了一种比传统ERP指标更敏感的方法,用于检测与遗传风险相关的微妙P300差异.
- 在APOE ε4载体中增加前部P300活性表明神经补偿机制支持保留的抑制控制.
- 这些发现突出了ERP和先进分析技术的潜力,用于识别与AD风险相关的早期,症状前的神经变化.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
7.9K
相关概念视频
Human Genetics
2.0K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
